These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33538979)

  • 1. Frequency and influence of "not relevant" responses on the Dermatology Life Quality Index among adults with atopic dermatitis.
    Barbieri JS; Chiesa Fuxench ZC; Shin DB; Takeshita J
    Qual Life Res; 2021 Jun; 30(6):1705-1713. PubMed ID: 33538979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
    Silverberg JI; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Fuxench ZC; Simpson EL
    Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.
    Barbieri JS; Shin DB; Syed MN; Takeshita J; Gelfand JM
    JAMA Dermatol; 2020 Apr; 156(4):446-450. PubMed ID: 32101261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
    Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study.
    Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Simpson EL; Ong PY; Chiesa Fuxench ZC
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):340-347. PubMed ID: 30025911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis.
    Silverberg JI; Gelfand JM; Margolis DJ; Fonacier L; Boguniewicz M; Schwartz LB; Simpson E; Grayson MH; Ong PY; Fuxench ZCC
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):464-468.e3. PubMed ID: 30003968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.
    Coutanceau C; Stalder JF
    Dermatology; 2014; 229(3):248-55. PubMed ID: 25196258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and Interpretation of Short Form 12 and Comparison with Dermatology Life Quality Index in Atopic Dermatitis in Adults.
    Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Chiesa Fuxench ZC; Simpson EL
    J Invest Dermatol; 2019 Oct; 139(10):2090-2097.e3. PubMed ID: 31009616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort.
    Silverberg JI; Simpson B; Abuabara K; Guttman-Yassky E; Calimlim B; Wegzyn C; Krueger W; Gamelli A; Munoz B; Faller RW; Crawford JM; Grada A; Eichenfield LF;
    J Am Acad Dermatol; 2023 Sep; 89(3):519-528. PubMed ID: 37150299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.
    Rencz F; Poór AK; Péntek M; Holló P; Kárpáti S; Gulácsi L; Szegedi A; Remenyik É; Hidvégi B; Herszényi K; Jókai H; Beretzky Z; Brodszky V
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):783-790. PubMed ID: 29114942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry.
    Guttman-Yassky E; Bar J; Rothenberg-Lausell C; Eichenfield L; Grada A; Abuabara K; Chapman M; Calimlim B; Wegzyn C; Gamelli A; Krueger W; Munoz B; Knapp K; Faller R; Crawford J; Silverberg J
    J Drugs Dermatol; 2023 Apr; 22(4):344-354. PubMed ID: 37026893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the U.K. and the U.S.A.
    Andersen L; Nyeland ME; Nyberg F
    Br J Dermatol; 2020 May; 182(5):1176-1183. PubMed ID: 31437300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atopic dermatitis is associated with a decrement in health-related quality of life.
    Kiebert G; Sorensen SV; Revicki D; Fagan SC; Doyle JJ; Cohen J; Fivenson D
    Int J Dermatol; 2002 Mar; 41(3):151-8. PubMed ID: 12010340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatology Life Quality Index in Patients with Atopic Dermatitis: Are "Not Relevant" Responses Relevant?
    Langenbruch A; Andrees V; Augustin M
    Dermatology; 2024; 240(4):653-658. PubMed ID: 38679001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS
    Silverberg JI; Lai JS; Patel KR; Singam V; Vakharia PP; Chopra R; Sacotte R; Kantor R; Hsu DY; Cella D
    Br J Dermatol; 2020 Nov; 183(5):891-898. PubMed ID: 32107772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding happiness to complement the Dermatology Quality of Life Index in psoriasis and atopic dermatitis healthcare: a cross-sectional study.
    Schuster B; Ziehfreund S; Schielein MC; Tizek L; Biedermann T; Peifer C; Zink A
    Eur J Dermatol; 2022 Apr; 32(2):220-226. PubMed ID: 35866912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rasch model analysis of two interpretations of 'not relevant' responses on the Dermatology Life Quality Index (DLQI).
    Rencz F; Mitev AZ; Szabó Á; Beretzky Z; Poór AK; Holló P; Wikonkál N; Sárdy M; Kárpáti S; Szegedi A; Remenyik É; Brodszky V
    Qual Life Res; 2021 Aug; 30(8):2375-2386. PubMed ID: 33683650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical observation on the efficacy and safety of dupilumab in the treatment of moderate to severe atopic dermatitis].
    Li CY; Chen S; Qian WL; Yang L; Zheng Q; Chen AJ; Chen J; Huang K; Fang S; Wang P; Hu L; Liu XR; Zhao XQ; Tan N; Cai T
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1590-1595. PubMed ID: 37859375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis.
    Schwartzman G; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY; Silverberg JI
    J Am Acad Dermatol; 2021 Sep; 85(3):636-644. PubMed ID: 33484762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Shower and Moisturizing Practices with Atopic Dermatitis Severity: A Prospective Longitudinal Cohort Study.
    Rakita U; Kaundinya T; Silverberg JI
    Dermatitis; 2023; 34(5):425-431. PubMed ID: 36917546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.